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Abstract
Introduction. Myocardial perfusion single-photon emission computed tomography (SPECT) is a diagnostic method using 
radionuclides to assess heart muscle perfusion. The aim of this study was to assess adherence to the European Socie-
ty of Cardiology (ESC) guidelines in referring patients to SPECT and to evaluate the occurrence of perfusion disorders 
depending on the type of indication.
Material and methods. The study included 100 outpatients (45 males), of mean age 65 ± 10 years, who were refer-
red for SPECT in the John Paul II Hospital in Kraków. According to the 2013 ESC Guidelines of stable coronary artery 
disease (CAD) management, indications for this study are those patients: with electrocardiogram (ECG) anomalies at 
rest, which prevent its accurate interpretation during stress (1st); with pacemaker (2nd); who are symptomatic with prior 
revascularisation (3rd); who are unable to exercise adequately during a stress test (4th); and with uncharacteristic chest 
pain (5th). Patients were divided into two groups according to their SPECT study result. Group 1 comprised patients with 
perfusion disorders, and Group 2 patients without perfusion disorders.
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Results. SPECT perfusion disorders were detected in 53 patients (53%) (these patients made up Group 1). Compliant 
with ESC Guidelines referrals included: 8% of patients with the 1st indication, 2% with the 2nd, 24% with the 3rd, 15% 
with the 4th and 23% with the 5th. Apart from the aforementioned indications, referrals including ‘CAD’ and ‘another 
heart arrhythmia’ were noted in 32% and 7%, respectively. From all the above mentioned ESC indications for SPECT, 
we observed statistically significant differences in the prevalence of perfusion disorders solely in patients with the 
3rd indication on their referrals (p = 0.013).
Conclusions. Overall, 72% of referrals in this study were compliant with ESC Guidelines. The most common indications 
for SPECT were ‘CAD’ and ‘symptomatic patients with prior revascularisation’. Only the group of patients with the 3rd in-
dication had statistically significantly more frequent perfusion disorders in SPECT.
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Referrals
According to the 2013 ESC Guidelines of Stable CAD Ma-
nagement [9], indications for this study are:
 — patients with electrocardiogram (ECG) anomalies at rest 
which prevent its accurate interpretation during stress;
 — patients with pacemaker;
 — symptomatic patients with prior revascularisation;
 — patients who are unable to exercise adequately during 
stress test;
 — patients with uncharacteristic chest pain.
SPECT protocol
All patients underwent the two-day 99mTc-sestamibi imaging 
protocol in accordance with the European Association of 
Nuclear Medicine procedural guidelines [10]. To provide the 
stress test, physical activity or pharmacological stressing 
was applied, depending on referral indications.
Exercise testing using the Bruce protocol was performed 
[10]. Endpoints of exercise stressing were:
 — reaching 85% of predicted maximum heart rate;
 — typical chest pain or equivalent (dyspnoea);
 — ischaemic ECG abnormalities: diagnostic horizontal or 
downsloping ST depression of > 2–3 mm;
 — significant ventricular or supraventricular arrhythmia 
on ECG;
 — a progressive reproducible decrease in systolic blood 
pressure;
 — abnormal elevation of systolic blood pressure and 
maximum stress (fatigue) [10].
Pharmacological testing is dedicated for patients with 
orthopaedic, neurological, or peripheral vascular disease 
and patients on beta-blocking medication, who are una-
ble to increase their heart rate adequately by physical 
exercise. Two pharmacological stressors were used in our 
study: dipyridamole or dobutamine, adequately to patients’ 
own contraindications. For every imaging session, 20 mCi 
(740 MBq) of 99mTc-methoxy isobutyl isonitrile (MIBI) was ad-
ministered. All SPECT studies were acquired on a Siemens 
Introduction
Myocardial perfusion single photon emission computed 
tomography (SPECT) is a non-invasive imaging method 
evaluating cardiac muscle perfusion with the use of ra-
dionuclides. Since SPECT’s introduction at the start of the 
1990s [1, 2], its role in diagnosing ischaemic heart disease 
has considerably increased. An improvement in the field 
of coronary heart disease (CAD) invasive treatment has 
been observed over recent decades. This has resulted in 
a growing number of patients surviving acute myocardial 
infarction (AMI). It has also given an opportunity to imple-
ment treatment in the early stages of CAD, prior to AMI. As 
a result, there has been increased interest in methods of 
assessing myocardial perfusion disorders, as well as left 
ventricular function after revascularisation procedures. 
Such interest has led to further development of SPECT, 
nowadays an established diagnostic method in CAD evalu-
ation. Currently SPECT is used for AMI risk stratification 
[3–6] and it guides clinicians in deciding whether a further 
diagnostic or therapeutic intervention should be considered 
[7, 8]. The experience gathered from almost 30 years of 
performing SPECT has helped to establish the European 
Society of Cardiology (ESC) Guidelines [9] for referring 
patients to this examination. Therefore, the purpose of our 
study was to assess the adherence to these guidelines in 
referring patients to SPECT and to evaluate the occurrence 
of perfusion disorders depending on the type of indication.
Material and methods
Patients
This retrospective observational study included 100 con-
secutive patients who were referred for a SPECT study in 
the John Paul II Hospital, Krakow. Data was obtained from 
patients’ referrals and SPECT study results. Our study 
examined SPECT scans performed between October and 
December 2017.
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Symbia gamma camera and were gated by ECG recording, 
which allowed us to calculate left ventricular ejection 
fraction (LVEF).
Statistical analysis
Shapiro-Wilk test was used to assess normality. The t-
-test was used for normally distributed variables, and the 
Mann-Whitney U test for non-normally distributed variables. 
Nominal variables were analysed using the Chi² test. In the 
analysis, differences were considered statistically signifi-
cant for a p-value less than 0.05. Statistical analysis was 
performed with RStudio v. 8.5.
Results
Baseline patient characteristics are set out in Table 1. Of 
the 100 patients, 45 were men. The mean age was 65 ye-
ars, with mean height: 166 centimetres (cm), mean weight: 
81.98 kilograms (kg), and mean body mass index (BMI): 
29.65 kg/m2. In this group 46% of patients were obese, i.e. 
with a cut-off value of BMI higher than 30 kg/m2.
To provide the stress test, 34 of the patients underwent 
pharmacological stressing. Among these 33 (97%) were 
given dipyridamole and in one (3%) patient with asthma 
dobutamine was administered. 66 patients underwent an 
exercise test. Among these, 25 (38%) reached at least 85% 
of the age-predicted maximum heart rate and the remaining 
41 (62%) failed to do so. The most common cause of early 
termination of the test was patient fatigue.
For statistical analysis, we divided patients into two 
groups: the first group with perfusion disorders revealed in 
SPECT (53 patients, which we called Group 1) and the se-
cond group, without abnormalities in myocardial perfusion 
(47 participants, Group 2). Group 1 included 29 (54.7%) 
men and 24 (45.3%) women, while in Group 2 there was 
a predominance of females [16 men (34%), 31 women 
(66%), p = 0.01]. The demographic characteristics of pa-
tients depending on their perfusion disorder occurrence 
are set out in Table 2. There was a statistically significant 
difference between the groups in mean values of weight 
(86.21 kg vs. 77.35 kg, p = 0.006) and BMI (30.8 kg/m2 vs. 
28.5 kg/m2, p = 0.03). Analysis of other parameters i.e. 
age and height did not demonstrate significant differences 
between the groups (p > 0.05).
Overall in this study 72% of referrals were compliant 
with ESC Guidelines. Table 3 shows the distribution of 
indications, according to the referrals, depending on 
the SPECT result. In the group with perfusion disorders, 
three patients (5.66%) had ECG anomalies at rest, which 
precluded its accurate interpretation during stress (the 
1st indication), one subject (1.89%) had a pacemaker (the 
2nd indication), 18 participants (33.96%) were referred as 
symptomatic patients with prior revascularisation (the 3rd in-
dication), seven patients (13.21%) were unable to exercise 
adequately during the stress test (the 4th indication), and 
10 people had uncharacteristic chest pain. In compari-
son, the group without perfusion disorders included: five 
(10.64%) patients who had ECG anomalies at rest which 
precluded its accurate interpretation during stress, one 
(2.13%) with a pacemaker, six (12.77%) who were referred 
as symptomatic patients with prior revascularisation, eight 
people (17.02%) were unable to exercise adequately during 
the stress test, and 13 participants (27.66%) were referred 
with uncharacteristic chest pain. As already stated, there 
was a statistically significant difference between the groups 
only in the prevalence of the 3rd indication (p = 0.013). 
Apart from the aforementioned indications, compliant 
Table 1. Baseline characteristics of all patients included in the 
study*
Parameter Value
Gender: male/female 45 (45%)/55 (55%)
Mean age [years] 65 ± 10.36
Mean height [cm] 166 ± 9
Mean weight [kg] 81.98 ± 17.44
Mean BMI [kg/m2] 29.65 ± 5.96
Overweight or obese 46 (46%)
*Variables are shown as mean values with standard deviation; BMI — body mass index
Table 2. Demographic profile of patients divided into two groups according to single-photon emission computed tomography (SPECT) 
study result: Group 1 — patients with perfusion disorders, Group 2 — patients without perfusion disorders
Parameter Group 1 (N = 53) Group 2 (N = 47) p value
Gender: male/female 29 (54.7%)/24 (45.3%) 16 (34%)/31 (66%) 0.01
Mean age [years] 65.04 ± 9.7 66.6 ± 11 0.2
Mean height [cm] 167 ± 9 165 ± 9 0.06
Mean weight [kg] 86.21 ± 17.66 77.35 ± 15.97 0.006
Mean BMI [kg/m2] 30.8 ± 5.91 28.5 ± 5.81 0.03
Overweight/obese 25 (47%) 19 (40%) 0.14
*Variables are shown as mean values with standard deviation; BMI — body mass index
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with the ESC guidelines, indications including ‘CAD’ and 
‘another heart arrhythmia’ were noted in this study. In the 
group with perfusion disorders, 14 (26.42%) patients had 
‘CAD’ on their referrals and two (3.77%) had an ‘another 
heart arrhythmia’ indication. Group 2 had 18 (38.30%) 
patients referred for SPECT with ‘CAD’ and five (10.64%) 
with ‘another heart arrhythmia’. Overall, there were no 
differences between the groups in terms of the prevalence 
of those indications (p = 0.2 for ‘CAD’ and p = 0.18 for 
‘another heart arrhythmia’).
Patients with perfusion disorders more often had 
a decreased left ventricular ejection fraction (LVEF) of 
below 55%, as opposed to Group 2 where the figures were 
[29 (55%) vs. 5 (11%), p < 0.01].
Discussion
In our study, we observed a predominance of males in 
the patients with abnormal SPECT study results (54.7% in 
Group 1 vs. 34% in Group 2). Shaw et al. [11] examined 
3,975 middle-aged patients referred for outpatient stress 
testing. The authors found that coronary revascularisation 
procedures were done more frequently in men (4.9% vs. 
2%, p = 0.03) which is associated with the higher perfusion 
disturbances prevalence in this group. The majority of pa-
tients referred to SPECT in this study were women (55%). 
A study by Hemal et al. [12] compared the two genders and 
proved that women were more often referred for imaging 
tests than for non-imaging tests. Women also were less 
likely to have a positive test result, which is compatible 
with our results (43.6% women vs. 64.4% men, p = 0.01).
Obesity is an increasing concern for healthcare pro-
viders worldwide [13]. In our study, 46% of the referred 
patients were overweight or obese. There was a trend 
towards a higher prevalence of overweight and obese in 
participants with perfusion disturbances found in SPECT 
study (47% vs. 40%, p = 0.14). Accordingly, the group with 
myocardial perfusion disorders had statistically significant 
higher BMIs than the group without perfusion disturbances 
(30.8 kg/m2 vs. 28.5 kg/m2). This finding is concordant 
with the current knowledge that these are independent 
risk factors for numerous cardiovascular diseases inclu-
ding CAD [14]. There are studies currently being carried 
out evaluating whether hormones produced by adipose 
tissue could be an independent risk factor for myocardial 
ischaemia. In the future, these could be used in clinical 
practice to assess the risk of CAD [15].
In our study, the most frequently used indication in 
patients referred to SPECT was: ‘symptomatic patient with 
prior revascularisation’. The number of these patients is 
high due to increasingly widespread use of revascularisa-
tion techniques, especially percutaneous coronary interven-
tion (PCI). In the case of patients who have undergone PCI in 
the past and now present with symptoms, physicians have 
to consider both restenosis and the progression of CAD. 
Casses et al. [16] found that in a group of 10,004 patients 
who underwent PCI, restenosis occurred in 26.4% of them. 
The risk of restenosis was lower when drug-eluting stents 
(DES) were used compared to bare-metal stents (BMS). 
Additionally, second-generation DESs posed a lower risk of 
restenosis than first-generation DESs. Despite the progres-
sion in the field of PCI, this complication is still considered 
a relevant difficulty.
The problem of symptoms recurrence also concerns 
patients after coronary artery bypass graft (CABG) proce-
dures. In this group, there are two main clinical problems in 
long term observation. The first is the progression of CAD in 
other arteries of coronary circulation [17]. The second is the 
durability of the graft. Goldman et al. reported that internal 
mammary artery grafts had 85% 10-year patency, while for 
saphenous vein grafts the 10-year patency was 61% [18].
In our study, 24 patients were referred with the abo-
vementioned indication. Perfusion disorders were detec-
ted in 18 of them (75%). According to previous studies, 
the occurrence of perfusion disorders in patients after 
revascularisation relevantly worsens the prognosis [19]. 
Our study showed that 75% of symptomatic patients with 
prior revascularisation had perfusion disorders in SPECT. 
Thus, a scintigraphy result may be especially useful in 
this group in establishing the best therapeutic approach 
Table 3. Distribution of indications for single-photon emission computed tomography (SPECT) study according to 2013 European Society 
of Cardiology guidelines on the management of stable coronary artery disease. Patients divided into two groups according to SPECT study 
result: Group 1 — patients with perfusion disorders, Group 2 — patients without perfusion disorders





ECG anomalies at rest which prevent its accurate interpretation during stress 3 (5.66%) 5 (10.64%) 0.36
Pacemaker 1 (1.89%) 1 (2.13%) 0.93
Symptomatic patient with prior revascularisation 18 (33.96%) 6 (12.77%) 0.013
Unable to exercise adequately during stress test 7 (13.21%) 8 (17.02%) 0.59
Non characteristic chest pain 10 (18.87%) 13 (27.66%) 0.3
ECG — electrocardiogram
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and in deciding about the subsequent invasive procedure. 
Our findings emphasise the risk of progression of CAD in 
symptomatic patients after cardiac revascularisation. Early 
diagnosis of CAD progression may decrease the number 
of additional diagnostic tests and, as a result, reduce the 
time to appropriate treatment implementation. Furthermo-
re, there is contraindicatory data relating to stress testing 
implementation, including myocardial perfusion SPECT, 
routinely after revascularisation procedures. The current 
guidelines of cardiological and nuclear medicine societies 
(e.g. ESC, European Association of Nuclear Medicine, 
Polish Cardiac Society) advise that the stress test not be 
performed after revascularisation as standard, given the 
fact that the usefulness of this diagnostic approach has not 
yet been investigated properly [8–10]. However, some data 
on routinely performed SPECT emphasises its potential 
benefits [20]. Despite the role of SPECT in the evaluation 
of symptomatic patients being well established, a routinely 
performed SPECT could bring about logistical problems for 
healthcare providers, due to issues such as the accessibility 
of the study and cost-effectiveness.
In our study, eight patients presented with ECG ano-
malies that meant it could not be accurately interpreted 
during the exercise test. Those abnormalities included an 
ST segment depression of 1 mm during rest ECG and left 
bundle branch block (LBBB). In general, patients with afore-
mentioned ECG changes are at a higher risk of death from 
CAD [21]. Nonetheless, the value of myocardial perfusion 
SPECT might be decreased in patients with LBBB. In this 
group, a false positive result may be observed due to the 
exercise anteroseptal perfusion disorders phenomenon 
[22]. Three (5.66%) of our participants had perfusion 
disorders, and five (10.64%) had a correct SPECT study 
result (p = 0.34).
The results of the studies support the statement that 
myocardial perfusion SPECT is a good method of risk stra-
tification in patients presenting with ECG anomalies that 
mean it cannot be accurately interpreted during an exercise 
test. Consequently, SPECT results are used to assess which 
of the patients is in need of revascularisation, and who 
would not benefit from this procedure [23].
Dominguez-Rodriguez et al. [24] assessed factors af-
fecting the adequacy of indications in referring to SPECT. 
Their analysis showed that experience gained since the 
completion of cardiology training influenced the referrals’ 
quality and the accuracy of the chosen study. Further-
more, some studies have proved that using appropriate 
indications for SPECT in the population with CAD is cost-
-effective [25].
Conclusion
Overall in this study 72% of referrals were compliant with 
ESC Guidelines. Apart from the aforementioned indications, 
referrals including ‘CAD’ and ‘heart arrhythmia’ were noted. 
Results from our study show that among ESC Guidelines 
indications for myocardial perfusion SPECT, the most 
common was exacerbation of symptoms in patients with 
prior revascularisation. Only this group of patients had 
statistically significantly more frequent perfusion disorders 
in SPECT. Overall, males and patients with a higher BMI 
were more prone to cardiac ischaemia. Moreover, patients 
with perfusion disorders in a SPECT study more often had 
decreased left ventricle systolic function.
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Streszczenie
Wstęp. Scyntygrafia perfuzyjna mięśnia sercowego wykonywana metodą tomografii emisyjnej pojedynczego fotonu 
(SPECT) jest badaniem diagnostycznym wykorzystującym izotopy do oceny aktywności biologicznej mięśnia sercowego. 
Celem niniejszego badania była ocena przestrzegania wytycznych Europejskiego Towarzystwa Kardiologicznego (ESC) 
w zakresie kierowania pacjentów na badanie SPECT i oceny występowania zaburzeń ukrwienia w zależności od rodzaju 
wskazania.
Materiały i metody. Do badania włączono 100 pacjentów ambulatoryjnych (45 mężczyzn) w średnim wieku 65 ± 10 lat, 
którzy zostali skierowani na badanie scyntygrafii perfuzyjnej mięśnia sercowego do Krakowskiego Szpitala Specjali-
stycznego im. Jana Pawła II w Krakowie. Zgodnie z wytycznymi ESC z 2013 roku dotyczącymi postępowania w stabilnej 
chorobie wieńcowej (CAD) na badanie SPECT powinni być skierowani pacjenci: z zaburzeniami elektrokardiograficznymi 
(EKG) w spoczynku, które uniemożliwiają ich poprawną interpretację w trakcie wysiłku (1.), z rozrusznikiem serca (2.), 
pacjenci wykazujący objawy po wcześniejszej rewaskularyzacji (3.), którzy nie są w stanie wykonać testu wysiłkowe-
go (4.), z nietypowymi bólami w klatce piersiowej (5.). Pacjentów podzielono na dwie grupy według wyniku badania 
SPECT (grupa 1. — pacjenci z zaburzeniami perfuzji, grupa 2. — pacjenci bez zaburzeń perfuzji).
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Wyniki. Zaburzenia perfuzji w badaniu SPECT wykryto u 53 pacjentów (53%) (grupa 1.). Przestrzeganie wytycznych ESC 
dotyczących wskazań do badania scyntygraficznego zaobserwowano kolejno u: 8% pacjentów z pierwszym wskazaniem, 
2% z drugim, 24% z trzecim, 15% z czwartym i 23% z piątym. Poza wymienionymi wyżej wskazaniami na skierowaniach 
pojawiły się również wskazania „CAD” i „inna arytmia serca” kolejno u 32% i 7% pacjentów. W odniesieniu do wszystkich 
wymienionych wyżej wskazań ESC dotyczących SPECT zaobserwowano statystycznie istotne różnice w zakresie częstości 
występowania zaburzeń perfuzji wyłącznie u pacjentów z trzecim wskazaniem na ich skierowaniach (p = 0,013).
Wnioski. Wśród skierowań na badanie scyntygraficzne mięśnia sercowego 72% było zgodnych z wytycznymi ESC 
z 2013 roku. Najczęściej pojawiającymi się wskazaniami były „CAD” i „objawowi pacjenci po wcześniejszej rewaskulary-
zacji”. Tylko w grupie pacjentów z trzecim wskazaniem statystycznie istotnie częściej występowały zaburzenia perfuzji 
w badaniu SPECT.
Słowa kluczowe: SPECT, choroba wieńcowa, perfuzja serca, scyntygrafia perfuzyjna
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